FNDC5 and type 2 diabetes mellitus: For example, the irisin concentrations in patients with type 2 diabetes mellitus are significantly lower compared to those without diabetes, whereas morbidly obese patients exhibit significantly elevated levels of irisin compared to individuals of normal body weight [57].